Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.01 +0.36 (+0.91%)
At close: Oct 22, 2026 · 4:00 PM EDT

Edgewise Therapeutics (EWTX) Return on Sales [ROS] (2024 - 2026)

Updated

Analysis

Edgewise Therapeutics (EWTX) Return on Sales [ROS] (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 24.35%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 37.86%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -3.52%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 32.97%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 20.57%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -133.21%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 28.37%
10 Edgewise Therapeutics 4.22 Bn 2.64 Bn - -1,341.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,341.92%
Mar 31, 2026 -1,060.66%
Sep 30, 2025 -756.75%
Jun 30, 2025 -656.04%
Mar 31, 2025 -890.51%
Dec 31, 2024 -774.75%
Sep 30, 2024 -641.47%
Jun 30, 2024 -576.51%
Mar 31, 2024 -558.01%
API Access

Edgewise Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EWTX&period=max&api_key=YOUR_API_KEY